Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) with peritoneal dissemination is a highly lethal disease. Recently, promising activity of intraperitoneal chemotherapy with paclitaxel (i.p.-PTX) has been observed in patients with peritoneal dissemination. We conducted a retrospective comparat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Tomohisa, Satoi, Sohei, Yamaki, So, Hashimoto, Daisuke, Ishida, Mitsuaki, Ikeura, Tsukasa, Hirooka, Satoshi, Matsui, Yuki, Boku, Shogen, Nakayama, Shinji, Nakamaru, Koh, Shibata, Nobuhiro, Katsushima, Utae, Sekimoto, Mitsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909716/
https://www.ncbi.nlm.nih.gov/pubmed/35267661
http://dx.doi.org/10.3390/cancers14051354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909716/
https://www.ncbi.nlm.nih.gov/pubmed/35267661
http://dx.doi.org/10.3390/cancers14051354

Ejemplares similares